Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis - A meta-analysis study

Yoshiki Miyachi, Ichiro Katayama, Masutaka Furue

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Combination of suplatast tosilate with tacrolimus ointment was reported to reduce the dose of tacrolimus ointment with maintained treatment efficacy for refractory facial erythema in atopic dermatitis (AD), however these were only case-controlled studies and the number of cases was not sufficiently large. Thus, the efficacy of a combination therapy of tacrolimus ointment and suplatast tosilate for treating AD including refractory facial erythema was investigated using a method of meta-analysis on the basis of published papers collected by database search. Methods: We searched the literature on the efficacy of a combination of topical tacrolimus and suplatast tosilate for refractory facial erythema in patients with adult atopic dermatitis, and related data were collected for meta-analysis. Results: Our meta-analysis study showed that suplatast/tacrolimus combination therapy revealed better improvement in skin symptom scores and significantly decreased the dose of tacrolimus compared with topical tacrolimus monotherapy. In addition, a significantly greater number of patients could stop using tacrolimus ointment by using the combination with suplatast tosilate than by tacrolimus monotherapy for refractory facial erythema. Conclusions: The combination therapy with suplatast tosilate decreased the effective dosage of tacrolimus ointment supporting use of the combination therapy for refractory facial erythema.

Original languageEnglish
Pages (from-to)269-275
Number of pages7
JournalAllergology International
Volume56
Issue number3
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Tacrolimus
Atopic Dermatitis
Erythema
Meta-Analysis
Ointments
Therapeutics
suplatast tosilate
Databases
Skin

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis - A meta-analysis study. / Miyachi, Yoshiki; Katayama, Ichiro; Furue, Masutaka.

In: Allergology International, Vol. 56, No. 3, 09.2007, p. 269-275.

Research output: Contribution to journalArticle

@article{58bca07a3b194643b8073879f2757d50,
title = "Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis - A meta-analysis study",
abstract = "Background: Combination of suplatast tosilate with tacrolimus ointment was reported to reduce the dose of tacrolimus ointment with maintained treatment efficacy for refractory facial erythema in atopic dermatitis (AD), however these were only case-controlled studies and the number of cases was not sufficiently large. Thus, the efficacy of a combination therapy of tacrolimus ointment and suplatast tosilate for treating AD including refractory facial erythema was investigated using a method of meta-analysis on the basis of published papers collected by database search. Methods: We searched the literature on the efficacy of a combination of topical tacrolimus and suplatast tosilate for refractory facial erythema in patients with adult atopic dermatitis, and related data were collected for meta-analysis. Results: Our meta-analysis study showed that suplatast/tacrolimus combination therapy revealed better improvement in skin symptom scores and significantly decreased the dose of tacrolimus compared with topical tacrolimus monotherapy. In addition, a significantly greater number of patients could stop using tacrolimus ointment by using the combination with suplatast tosilate than by tacrolimus monotherapy for refractory facial erythema. Conclusions: The combination therapy with suplatast tosilate decreased the effective dosage of tacrolimus ointment supporting use of the combination therapy for refractory facial erythema.",
author = "Yoshiki Miyachi and Ichiro Katayama and Masutaka Furue",
year = "2007",
month = "9",
doi = "10.2332/allergolint.O-06-478",
language = "English",
volume = "56",
pages = "269--275",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "3",

}

TY - JOUR

T1 - Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis - A meta-analysis study

AU - Miyachi, Yoshiki

AU - Katayama, Ichiro

AU - Furue, Masutaka

PY - 2007/9

Y1 - 2007/9

N2 - Background: Combination of suplatast tosilate with tacrolimus ointment was reported to reduce the dose of tacrolimus ointment with maintained treatment efficacy for refractory facial erythema in atopic dermatitis (AD), however these were only case-controlled studies and the number of cases was not sufficiently large. Thus, the efficacy of a combination therapy of tacrolimus ointment and suplatast tosilate for treating AD including refractory facial erythema was investigated using a method of meta-analysis on the basis of published papers collected by database search. Methods: We searched the literature on the efficacy of a combination of topical tacrolimus and suplatast tosilate for refractory facial erythema in patients with adult atopic dermatitis, and related data were collected for meta-analysis. Results: Our meta-analysis study showed that suplatast/tacrolimus combination therapy revealed better improvement in skin symptom scores and significantly decreased the dose of tacrolimus compared with topical tacrolimus monotherapy. In addition, a significantly greater number of patients could stop using tacrolimus ointment by using the combination with suplatast tosilate than by tacrolimus monotherapy for refractory facial erythema. Conclusions: The combination therapy with suplatast tosilate decreased the effective dosage of tacrolimus ointment supporting use of the combination therapy for refractory facial erythema.

AB - Background: Combination of suplatast tosilate with tacrolimus ointment was reported to reduce the dose of tacrolimus ointment with maintained treatment efficacy for refractory facial erythema in atopic dermatitis (AD), however these were only case-controlled studies and the number of cases was not sufficiently large. Thus, the efficacy of a combination therapy of tacrolimus ointment and suplatast tosilate for treating AD including refractory facial erythema was investigated using a method of meta-analysis on the basis of published papers collected by database search. Methods: We searched the literature on the efficacy of a combination of topical tacrolimus and suplatast tosilate for refractory facial erythema in patients with adult atopic dermatitis, and related data were collected for meta-analysis. Results: Our meta-analysis study showed that suplatast/tacrolimus combination therapy revealed better improvement in skin symptom scores and significantly decreased the dose of tacrolimus compared with topical tacrolimus monotherapy. In addition, a significantly greater number of patients could stop using tacrolimus ointment by using the combination with suplatast tosilate than by tacrolimus monotherapy for refractory facial erythema. Conclusions: The combination therapy with suplatast tosilate decreased the effective dosage of tacrolimus ointment supporting use of the combination therapy for refractory facial erythema.

UR - http://www.scopus.com/inward/record.url?scp=34548857048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548857048&partnerID=8YFLogxK

U2 - 10.2332/allergolint.O-06-478

DO - 10.2332/allergolint.O-06-478

M3 - Article

C2 - 17582208

AN - SCOPUS:34548857048

VL - 56

SP - 269

EP - 275

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 3

ER -